Talphera Inc (FRA:R5XA)
€ 0.829 0.002 (0.24%) Market Cap: 13.90 Mil Enterprise Value: 4.42 Mil PE Ratio: 0 PB Ratio: 1.19 GF Score: 42/100

Q4 2023 Talphera Inc Earnings Call Transcript

Mar 06, 2024 / 09:30PM GMT
Release Date Price: €1.13 (-3.75%)
Operator

Welcome to the Telfer era Fourth Quarter 2023 financial results conference call. This call is being webcasted live via the Events page of the Investors section of healthcare's website, triple w. dot telkom.com. This call is the property of tall fair and any recording, reproduction or transmission of this call without the express written consent of Telstra is strictly prohibited. As a reminder, this webcast is being recorded. You may listen to a replay of this webcast by going to the Investors section of Telstra's website.

I would now like to turn the call over to Raffi Ecuadorian Solzira Pharmaceuticals' Chief Financial Officer. Please go ahead.

Raffi Asadorian
Talphera Inc - Chief Financial Officer

Thank you for joining us on the call today. This afternoon, we announced our fourth quarter 2023 financial results and associated business plan business updates in a press release. This press release can be found within the Investors section of our website.

With me today are Vince Angotti, our Chief Executive Officer, and Dr. Pam Palmer,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot